PROVIDES THE AGENCY WITH THE
INFORMATION REQUIRED TO AID IN THE ASSURANCE THAT MEDICATED FEEDS
WILL BE MANUFACTURED IN ACCORDANCE WITH THE FD&C ACT AND ITS
REGULATIONS CONCERNING PROPER MANUFACTURING AND LABELING OF NEW
ANIMAL DRUG PREMIXES. AN EXTENSION OF TIME IS REQUIRED TO ALLOW FOR
THE PUBLICATION OF THE NEW SECOND GENERATION PROGRAM WHICH WILL USE
THE FORM FDA 1900.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.